Concepedia

Publication | Open Access

Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer (“METRIC”): a randomized multicenter study

DOIFull Paper Access

52

Citations

26

References

2021

Year

Linda T. Vahdat, Peter Schmid, Andres Forero‐Torres, Kimberly Blackwell, Melinda L. Telli, Michelle Melisko, Volker Möbus, Javier Cortés, Alberto J. Montero, Rita Nanda,
npj Breast Cancer

References

YearCitations

Page 1